References
- Anderson, I.M., Nutt, D.J., & Deakin, J.F. (2000). Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. Journal of Psychopharmacoogyl, 14, 3–20.
- Andrade, C., & Rao, N.S. (2010). How antidepressant drugs act: A primer on neuroplasticity as the eventual mediator of antidepressant efficacy. Indian Journal of Psychiatry 52(4):378–386. doi: 10.4103/0019-5545.74318.
- Aydemir, O., Deveci, A., & Taneli, F. (2005). The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: A preliminary study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 261–265.
- Aydemir, O., Deveci, A., Taskin, O.E., Taneli, F., & Esen-Danaci, A. (2007). Serum brain-derived neurotrophic factor level in dysthymia: A comparative study with major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 1023–1026.
- Bravo, J.A., Diaz-Veliz, G., Mora, S., Ulloa, J.L., Berthoud, V.M., Morales, P., … Fiedler, J.L. (2009). Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behavioural Pharmacology, 20, 273–285. doi: 10.1097/FBP.0b013e32832c70d9
- Christensen, M.V., & Kessing, L.V. (2001). The hypothalamo-pituitary-adrenal axis in major affective disorder: A review. Nordic Journal of Psychiatry, 55(5), 359–363.
- Duman, R.S., & Monteggia, L.M. (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry, 59(12), 1116–1127.
- Gangadhar, B.N., Naveen, G.H., Rao, M.G., Thirthalli, J., & Varambally, S. (2013). Positive antidepressant effects of generic yoga in depressive out-patients: A comparative study. Indian Journal of Psychiatry, 55, 369–373.doi:10.4103/0019-5545.116312.
- Gervasoni, N., Aubry, J.M., Bondolfi, G., Osiek, C., Schwald, M., Bertschy, G., & Karege, F. (2005). Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology, 51(4), 234–238.
- Gillespie, C.F., & Nemeroff, C.B. (2005). Hypercortisolemia and depression. Psychosomatic Medicine, 67(Suppl 1), S26–S28.
- Gold, S.M., Kern, K.C., O'Connor, M.F., Montag, M.J., Kim, A., Yoo, Y.S., … Sicotte, N.L. (2010). Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biological Psychiatry, 68(6), 553–559.
- Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62.
- Janakiramaiah, N., Gangadhar, B.N., Naga Venkatesha Murthy, P.J., Harish, M.G., Subbakrishna, D.K., & Vedamurthachar, A. (2000). Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine. Journal of Affective Disorders, 57(1–3), 255–259.
- Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., & Aubry, J.M. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research, 109(2), 143–148.
- Knoops, A.J., Gerritsen, L., van der Graaf, Y., Mali, W.P., & Geerlings, M.I. (2010). Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: the SMART-Medea study. Biological Psychiatry, 67(12), 1191–1198.
- Leonard, B.E. (2000). Evidence for a biochemical lesion in depression. Journal of Clinical Psychiatry, 61(Suppl 6), 12–17.
- Lupien, S.J., de Leon, M., de Santi, S., Convit, A., Tarshish, C., Nair, N.P., … Meaney, M.J. (1998). Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature Neuroscience, 1(1), 69–73.
- Manji, H.K., Quiroz, J.A., Sporn, J., Payne, J.L., Denicoff, K., Neil, A.G., … Charney, D.S. (2003). Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biological Psychiatry, 53(8), 707–742.
- Naveen, G.H., Thirthalli, J., Rao, M.G., Varambally, S., Christopher, R., & Gangadhar, B.N. (2013). Positive therapeutic and neurotropic effects of yoga in depression: A comparative study. Indian Journal of Psychiatry, 55(Suppl 3), S400–S404.
- Pan, W., Banks, W.A., Fasold, M.B., Bluth, J., & Kastin, A.J. (1998). Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology, 37(12), 1553–1561.
- Ren-Patterson, R.F., Cochran, L.W., Holmes, A., Sherrill, S., Huang, S.J., Tolliver, T., Lesch, K.P., Lu, B., Murphy, D.L. (2005). Loss of brain-derived neurotrophic factor gene allele exacerbates brain monoamine deficiencies and increases stress abnormalities of serotonin transporter knockout mice. Journal of Neuroscience Research, 79(6), 756–771.
- Ruhe, H.G., Mason, N.S., & Schene, A.H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: A meta-analysis of monoamine depletion studies. Molecular Psychiatry, 12(4), 331–359.
- Schaaf, M.J., de Jong, J., de Kloet, E.R., & Vreugdenhil, E. (1998). Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Research, 813(1), 112–120.
- Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., … Dunbar, G.C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22–33; quiz 34–57.
- Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., … Iyo, M. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry, 54(1), 70–75.
- Smith, M.A., Makino, S., Kvetnansky, R., & Post, R.M. (1995). Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. The Journal of Neuroscience, 15(3 Pt 1), 1768–1777.
- Thirthalli, J., Naveen, G.H., Rao, M.G., Varambally, S., Christopher, R., & Gangadhar, B.N. (2013). Cortisol and antidepressant effects of yoga. Indian Journal of Psychiatry, 55(Suppl 3), S405–S408.
- Varambally, S., Naveen, G.H., Rao, M.G., Thirthalli, J., Sharma, R., Christopher, R., & Gangadhar, B.N. (2013). Low serum brain derived neurotrophic factor in non-suicidal out-patients with depression: Relation to depression scores. Indian Journal of Psychiatry, 55(Suppl 3), S397–S399.
- Vedamurthachar, A., Janakiramaiah, N., Hegde, J.M., Shetty, T.K., Subbakrishna, D.K., Sureshbabu, S.V., & Gangadhar, B.N. (2006). Antidepressant efficacy and hormonal effects of Sudarshana Kriya Yoga (SKY) in alcohol dependent individuals. Journal of Affective Disorders, 94(1-3), 249–253.
- Videbech, P., & Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. American Journal of Psychiatry, 161(11), 1957–1966.
- World Health Organization. (2001). The World Health Report-Mental Health: New Understanding, New Hope. Geneva: NMH Communications (G. NMH Communications, Trans.).